ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
5 hedge funds and large institutions have $677K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Holders
5
Holding in Top 10
–
Calls
$575K
Puts
$168K
Top Sellers
| 1 | -$415K | |
| 2 | -$108K | |
| 3 | -$104K | |
| 4 |
GHAM
Gilman Hill Asset Management
New Canaan,
Connecticut
|
-$104K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$18.3K |